A real-world analysis of nanoliposomal-irinotecan with 5-fluorouracil and folinic acid as third- or later-line therapy in patients with metastatic pancreatic adenocarcinoma

BACKGROUND: Nanoliposomal encapsulation of irinotecan (nal-IRI) with 5-fluorouracil and leucovorin (5-FU/LV) has shown a survival benefit for gemcitabine-pretreated patients with metastatic pancreatic adenocarcinoma (mPAC). The aim of this study was to evaluate the effectiveness and safety of nal-IR...

Descripción completa

Detalles Bibliográficos
Autores principales: Chun, Jung Won, Woo, Sang Myung, Lee, Sang Hyub, Choi, Jin Ho, Park, Namyoung, Kim, Joo Seong, Cho, In Rae, Paik, Woo Hyun, Lee, Woo Jin, Ryu, Ji Kon, Kim, Yong-Tae
Formato: Online Artículo Texto
Lenguaje:English
Publicado: SAGE Publications 2022
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9434681/
https://www.ncbi.nlm.nih.gov/pubmed/36062047
http://dx.doi.org/10.1177/17588359221119539

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9434681/
https://www.ncbi.nlm.nih.gov/pubmed/36062047
http://dx.doi.org/10.1177/17588359221119539

Ejemplares similares